Corporate
Jasper Therapeutics Ousts CEO Ron Martell After 97% Stock Collapse, Promotes COO Amid Turnaround Effort
Jan 7
You're signed outSign in or to get full access.
JT
Jasper Therapeutics (JSPR)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Jasper Therapeutics.